Get access to our best features
Get Started
Subscribe
Get access to our best features
Get Started
mdedge.com image

News from mdedge.com

If you want to know if mdedge.com is credible or reliable, look no further. We rank mdedge.com as unknown factuality. Find out more about our methodology here.

Information about mdedge.com

Where is mdedge.com located?mdedge.com's Website

Factuality

How credible is the news from mdedge.com?
Unknown
by Ad Fontes Media and Media Bias/Fact Check
Learn more about Factuality Ratings.

Media Bias Ratings

Does mdedge.com lean left or right?
Learn more about Media Bias Ratings.

Top mdedge.com News

FDA Mandates Changes to iPLEDGE Program for Isotretinoin

FDA Mandates Changes to iPLEDGE Program for Isotretinoin

Isotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin. MDedge NewsSee the Story
Even With Insurance, Cancer Out-of-Pocket Costs Can Be Punishing
Insurance

Even With Insurance, Cancer Out-of-Pocket Costs Can Be Punishing

Commercial health insurance does not necessarily protect cancer patients from potentially devastating out-of-pocket costs.See the Story
How to Address Chemo-Related Amenorrhea in Early Breast Cancer to Help Improve Quality of Life
Canada Revenue Agency

How to Address Chemo-Related Amenorrhea in Early Breast Cancer to Help Improve Quality of Life

Persistent chemotherapy-related amenorrhea (CRA) after treatment for breast cancer was common and associated with worse long-term quality of life among premenopausal women.See the Story

Latest News Stories

Hidradenitis Suppurativa: Positive Results Reported With Anti-IL17A/F Therapies

One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.See the Story

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.See the Story
Tobacco

Quitting Tobacco Can Improve Lung Health in COPD

Reducing exposure to tobacco smoke may reduce the burden of chronic obstructive pulmonary disease, and public health measures are needed.See the Story
Medical

Studies Support Early Use of Urate-Lowering Therapy, Warn of Peripheral Arterial Disease

A new analysis suggests that it may not be necessary to delay urate-lowering therapy in gout flares, and a study warns of the potential heightened risk for peripheral arterial disease in gout.See the Story
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsSubscribeGiftFree TrialCareersFor Educators/LibrariesAffiliates
HelpHelp CenterFAQContact UsMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyTerms and Conditions
© 2023 Snapwise Inc.
News
For You
Search
BlindspotLocal